AGF Management’s Gilead Sciences GILD Stock Holding History

AGF Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.25M	Buy	52,008 +25,946	+100%	+$3.63M	0.03%	231
2025 Q4	$3.2M	Buy	26,062 +3,159	+14%	+$384K	0.01%	333
2025 Q3	$2.54M	Buy	22,903 +10,303	+82%	+$1.17M	0.01%	467
2025 Q2	$1.4M	Buy	+12,600	New	+$1.34M	0.01%	502
2024 Q4	–	Sell	-40,856	Closed	-$3.43M	–	709
2024 Q3	$3.43M	Buy	40,856 +3,831	+10%	+$292K	0.02%	330
2024 Q2	$2.54M	Sell	37,025 -9,462	-20%	-$631K	0.01%	346
2024 Q1	$3.41M	Sell	46,487 -205	-0.4%	-$15.8K	0.02%	305
2023 Q4	$3.78M	Sell	46,692 -2,327	-5%	-$181K	0.02%	303
2023 Q3	$3.67M	Sell	49,019 -4,323	-8%	-$333K	0.03%	284
2023 Q2	$4.11M	Buy	53,342 +4,749	+10%	+$379K	0.03%	274
2023 Q1	$4.03M	Sell	48,593 -61,578	-56%	-$5.1M	0.03%	291
2022 Q4	$9.46M	Buy	+110,171	New	+$8.72M	0.07%	201

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AGF Management's GILD Position: Q1 2026 in Review

AGF Management increased its Gilead Sciences (GILD) stake by 100% in Q1 2026, buying an estimated $3.63M and bringing the position to 52,008 shares worth $7.25M. The position accounts for 0.03% of the portfolio, ranked #231.

AGF Management first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. The position peaked at $9.46M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

AGF Management held 52,008 shares of Gilead Sciences worth $7.25M as of Q1 2026.
AGF Management bought 25,946 Gilead Sciences shares in Q1 2026, an estimated $3.63M.
Gilead Sciences made up 0.03% of AGF Management's portfolio in Q1 2026, its #231 holding.
AGF Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
AGF Management's Gilead Sciences position peaked at $9.46M in Q4 2022.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.